Download Forelesningsserie, veksthormon(er) v/Jan O. Gordeladze )

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Forelesningsserie, veksthormon(er)
v/Jan O. Gordeladze
• Endokrin regulering av:
• vekst (veksthormon)
• basal metabolisme (også thyroideahormoner)
• ”alt mulig” (også glukokortikoidhormoner)
Endokrin regulering
• Endokrine kjertler frisetter kjemiske forbindelser,
hormoner, fra kjertelceller til ekstracellulær væske, blod
• Diffunderer og transporteres gjennom kroppen
• Reagerer med spesifikke reseptorer for å fremkalle
cellulære endringer.
Endokrine Kjertler
• 7 hovedgrupper:
•
•
•
•
•
•
•
Hypofyse
Skjoldbruskkjertel (thyroid gland)
Biskjoldbruskkjertel (parathyroid)
Testis
Ovary
Adrenal gland
Pancreas
• Pluss CNS, tarm, lokale celler (”faktorer”)
Hormongrupper
• Peptider: insulin, glukagon, ACTH, GH, TSH, TRH
• Aminosyrederivater: katekolaminer, indolaminer,
tyrosinderivater
• Steroider: aldosteron, kortisol, progesteron, østrogen,
testosteron
Hormonmetabolisme
• Syntese: i spesifikke celler
• Frisetting: eksocytose eller andre mekanismer
• Transport: Fritt i plasma (peptider, aminosyrer) vs.
proteinbundet (steroider)
• Nedbrytning: Oftest lever, nyre
• Utskilles: Urin, tarm
Funksjonell homeostase
• Enkel tilbakemelding (”feed back”)
• Eksempel: nivåer av glukose – ßceller insulin - glukose
• Hierarkisk regulering: via CNS, hypofyse.
• Eksempel: binyrebarkhormoner - CRH - ACTH binyrebarkceller
Downloaded from: StudentConsult (on 28 January 2011 01:28 PM)
© 2005 Elsevier
Downloaded from: StudentConsult (on 28 January 2011 01:28 PM)
© 2005 Elsevier
Growth hormone (somatropin)
• Protein, 2(3) variants, 191 or 176 a.a.
• Synthesized in somatotrophs in anterior pituitary
• Stored in secretory granules, released by Ca2+dependent exocytosis
Downloaded from: StudentConsult (on 28 January 2011 01:28 PM)
© 2005 Elsevier
Downloaded from: StudentConsult (on 28 January 2011 01:28 PM)
© 2005 Elsevier
Effects of GH
• Acute effects – diabetogenic:
•
•
•
•
Decrease glucose uptake
Increase lipolysis
Increase glukoneogenesis
Induce insulin resistance
• Long Term Effects – bodily growth:
• Mediated by insulin-like growth factor-I (IGF-I)
• IGF-I is synthesized/released by GH-receptor activation in most
tissues
• IGF-I receptor: tyrosine kinase – ras-mediated effect.
Veksthormon=
Growth
Hormone =
GH
VIRKER
på nesten
ALT
VEV
Tyrosin-kinase reseptoren dimeriserer,
fosforyleres og P-grppene binder forskjellige
signalproteiner
Tyrosinkinase-assosiert reseptor
GH virker via
en tyrosinkinaseassosiert
reseptor
Tyrosin kinase reseptorer
IGF virker via en
tyrosin-kinase
reseptor.
Her er tre typer
av disse
reseptorene
Akromegali
Gigantisme
Akromegali eller gigantisme
• ØKT SEKRESJON AV VEKSTHORMON FØR
AVSLUTTET LENGDEVEKST: GIGANTISME
• ØKT SEKRESJON AV VEKSTHORMON
ETTER AVSLUTTET LENGDEVEKST:
AKROMEGALI
Dvergvekst
• MANGLENDE SEKRESJON AV
VEKSTHORMON I OPPVEKSTEN (kan
også skyldes manglende reseptor for GH)
• KORTVOKST; under 120 cm, men med
normale proporsjoner
• Hvis ikke andre hormonforstyrrelser,
normal kjønnsutvikling
Quiz:
Er de fysiologiske
effektene av veksthormon
alltid direkte på målcellene?
Begrunn svaret.
Downloaded from: StudentConsult (on 28 January 2011 01:28 PM)
© 2005 Elsevier
Downloaded from: StudentConsult (on 28 January 2011 01:28 PM)
© 2005 Elsevier
IGF-I-mediated regulation of GH release
• IGF-I effects on CNS
• on anterior pituitary somatotrophs
Downloaded from: StudentConsult (on 28 January 2011 01:28 PM)
© 2005 Elsevier
Other growth-regulating hormones
• Thyroid - lack of gives cretinism, dwarfism
• Cortisol - lack of gives dwarfism
• Sex hormones – puberty determines end of growth
period
• Insulin - lack of gives Langerhans’ islets «type» dwarfism
Clinical Relevance
• Before puberty
• Lack of GH/IGF-I: dwarfism (0.9 m body size)
• Excess of GH/IGF-I: gigantism (2.7 m body size)
• After puberty (growth zones closed)
• Excess of GH/IGF-I: Acromegaly (expansive skeletal growth,
multiple problems, diabetes, heart failure etc)
Multiple choice 1-5:
Which of the following statement(s) is/are false?
1) GH-release from the pituitary is stimulated by GHRH, but inhibited by
Somatostatin (ST)
2) GH-release is mediated by the PLC-pathway (enhanced DAG and IP3) via
mobilization of intracellular Ca2+.
3) The acute effects of GH are: decreased glucose uptake, increased lipolysis,
decreased gluconeogenesis, induced insulin resistance, enhanced lean body mass.
4) GH-induced IGF-1 (synthesized by the liver) is inhibiting the GH-release via
negative feed-back on GHRH-secretion, and negative feed-back on ST
(hypothalamus), and direct negative feed-back on the pituitary.
5) The pubertal peak rate of growth corresponds to the peak serum concentration
of IGF-II.